Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor, ...
OLATHE, Kan., Oct. 25, 2018 /PRNewswire/ -- ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in companion animals, announced results from its canine ...
"My dog has a tumor that has just popped up on her bottom jaw, and it's getting rather big rather fast. It's kind of hard and feels like a muscle. Do you think ivermectin might help? She is only 5 or ...
LENEXA, Kan., June 19, 2025 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced interim results from an ongoing clinical study evaluating ELIAS ...
Two canine osteosarcoma patients who underwent amputations are shown in 2023, when their care team and owners celebrated their final chemo treatments by ringing a bell and giving both dogs lots of ...
U.S. Department of Agriculture Center for Veterinary Biologics approves ECI®, a first-in-class adoptive cell therapy for the treatment of bone cancer in dogs ECI® is now available at 100 authorized ...
In a first-of-its-kind study, scientists have helped advance a patient-specific, precision medicine treatment for bone cancer in dogs. By creating a vaccine from a dog’s own tumor, scientists at the ...
In recognition of Childhood Cancer Awareness Month, Live Like Madison has partnered with the V Foundation for Cancer Research ...
Austin, TX, Feb. 02, 2022 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®), for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback